Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug 15;2012(8):CD005426.
doi: 10.1002/14651858.CD005426.pub3.

Nutritional support for acute kidney injury

Affiliations

Nutritional support for acute kidney injury

Yi Li et al. Cochrane Database Syst Rev. .

Abstract

Background: Treatment for acute kidney Injury (AKI) primarily relies on treating the underlying cause and maintaining the patient until kidney function has recovered. Enteral and parenteral nutrition are commonly used to treat nutritional disorders in AKI patients, however their efficacy in treating AKI are still debated. This review was first published in 2010.

Objectives: To evaluate the effectiveness and safety of nutritional support for patients with AKI.

Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, Chinese Biomedical Disc, VIP and China National Knowledge Infrastructure (CNKI).Date of last search: 4 July 2012

Selection criteria: All randomised controlled trials (RCTs) reported for AKI and nutrition were included.

Data collection and analysis: Authors independently assessed study quality and extracted data. Results were expressed as risk ratio (RR) with 95% confidence intervals (CI) or mean difference (MD).

Main results: Eight studies (257 participants) were included. An overall pooled analysis was not performed due to the different interventions used and different outcomes measured. Selection bias was not reported (unclear) in six studies and was adequately reported (low) for random sequence generation in two studies. Participant/personnel blinding was adequately reported in one study and unclear in seven. Incomplete outcome reporting bias was low in six studies and high in two. Selective reporting was low in six studies, unclear in one study, and high in one study. No other biases were detected. There was a significant increase in recovery rate for AKI (RR 1.70, 95% CI 1.70 to 2.79) and survival in dialysed patients (RR 3.56, 95% CI 0.97 to 13.08) for intravenous essential L-amino acids (EAA) compared to hypertonic glucose alone. Compared to lower calorie-total parenteral nutrition (TPN), higher calorie-TPN did not improve estimated nitrogen balance, protein catabolic rate, or urea generation rate; but increased serum triglycerides, glucose, insulin need and nutritional fluid administration. There was no difference between groups in estimated nitrogen balance, but there were differences between urea nitrogen appearance (MD 0.98, 95% CI 0.25 to 1.71) and net protein utilisation (MD 21.50%, 95% CI 0.39 to 42.61). Urea nitrogen appearance was lower in the low nitrogen intake group than in the high nitrogen intake group. There was no significant difference in death between EAA and general amino acids (GAA) (RR 1.52, 95% CI 0.63 to 3.68). High dose amino acids did not improve cumulative water excretion, furosemide requirement, nitrogen balance or death compared to normal dose amino acids. Glucose+EAA+histidin had better nitrogen balance than glucose+GAA; glucose+nitrogen+fat significantly increased serum creatinine compared with glucose+GAA; glucose+EAA+histidin significantly improved nitrogen balance, U/P urea and serum creatinine, but increased plasma urea compared to glucose+nitrogen+fat.

Authors' conclusions: There was insufficient evidence found to support the effectiveness of nutritional support for AKI. Further high quality studies are required to provide reliable evidence of the effect and safety of nutritional support.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1
1
Study flow diagram of included studies
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
1.1
1.1. Analysis
Comparison 1 Essential L‐amino acids (ELAA) versus glucose, Outcome 1 Recovery from acute kidney injury.
1.2
1.2. Analysis
Comparison 1 Essential L‐amino acids (ELAA) versus glucose, Outcome 2 Survival on dialysis.
1.3
1.3. Analysis
Comparison 1 Essential L‐amino acids (ELAA) versus glucose, Outcome 3 Average slope of serum creatinine.
1.4
1.4. Analysis
Comparison 1 Essential L‐amino acids (ELAA) versus glucose, Outcome 4 Average slope of blood urea nitrogen.
1.5
1.5. Analysis
Comparison 1 Essential L‐amino acids (ELAA) versus glucose, Outcome 5 Serum creatinine.
1.6
1.6. Analysis
Comparison 1 Essential L‐amino acids (ELAA) versus glucose, Outcome 6 Serum proteins.
1.7
1.7. Analysis
Comparison 1 Essential L‐amino acids (ELAA) versus glucose, Outcome 7 Urea nitrogen appearance.
2.1
2.1. Analysis
Comparison 2 High essential and nonessential amino acid (ENAA) nitrogen intake versus low essential amino acid (EAA) nitrogen intake, Outcome 1 Urea nitrogen appearance.
2.2
2.2. Analysis
Comparison 2 High essential and nonessential amino acid (ENAA) nitrogen intake versus low essential amino acid (EAA) nitrogen intake, Outcome 2 Estimated protein nitrogen balance.
3.1
3.1. Analysis
Comparison 3 Essential amino acids (EAA) versus general amino acids (GAA), Outcome 1 Death.
3.2
3.2. Analysis
Comparison 3 Essential amino acids (EAA) versus general amino acids (GAA), Outcome 2 Estimated protein nitrogen balance.
3.3
3.3. Analysis
Comparison 3 Essential amino acids (EAA) versus general amino acids (GAA), Outcome 3 Urea nitrogen appearance.
3.4
3.4. Analysis
Comparison 3 Essential amino acids (EAA) versus general amino acids (GAA), Outcome 4 Net protein utilisation.
4.1
4.1. Analysis
Comparison 4 High‐dose amino acids (AA) versus normal‐dose AA, Outcome 1 Death.
4.2
4.2. Analysis
Comparison 4 High‐dose amino acids (AA) versus normal‐dose AA, Outcome 2 Haemodialysis requirement.
4.3
4.3. Analysis
Comparison 4 High‐dose amino acids (AA) versus normal‐dose AA, Outcome 3 Cumulative nitrogen balance.
4.4
4.4. Analysis
Comparison 4 High‐dose amino acids (AA) versus normal‐dose AA, Outcome 4 Furosemide requirement.
5.1
5.1. Analysis
Comparison 5 Glucose+EAA+histidin versus glucose+GAA, Outcome 1 Nitrogen balance.
5.2
5.2. Analysis
Comparison 5 Glucose+EAA+histidin versus glucose+GAA, Outcome 2 Plasma urea.
5.3
5.3. Analysis
Comparison 5 Glucose+EAA+histidin versus glucose+GAA, Outcome 3 U/P urea.
5.4
5.4. Analysis
Comparison 5 Glucose+EAA+histidin versus glucose+GAA, Outcome 4 Serum creatinine.
5.5
5.5. Analysis
Comparison 5 Glucose+EAA+histidin versus glucose+GAA, Outcome 5 Urea nitrogen appearance.
5.6
5.6. Analysis
Comparison 5 Glucose+EAA+histidin versus glucose+GAA, Outcome 6 Serum proteins.
6.1
6.1. Analysis
Comparison 6 Glucose+EAA+histidin versus glucose+nitrogen+fat, Outcome 1 Nitrogen balance.
6.2
6.2. Analysis
Comparison 6 Glucose+EAA+histidin versus glucose+nitrogen+fat, Outcome 2 Plasma urea.
6.3
6.3. Analysis
Comparison 6 Glucose+EAA+histidin versus glucose+nitrogen+fat, Outcome 3 U/P urea.
6.4
6.4. Analysis
Comparison 6 Glucose+EAA+histidin versus glucose+nitrogen+fat, Outcome 4 Serum creatinine.
7.1
7.1. Analysis
Comparison 7 Glucose+GAA versus glucose+nitrogen+fat, Outcome 1 Nitrogen balance.
7.2
7.2. Analysis
Comparison 7 Glucose+GAA versus glucose+nitrogen+fat, Outcome 2 Plasma urea.
7.3
7.3. Analysis
Comparison 7 Glucose+GAA versus glucose+nitrogen+fat, Outcome 3 U/P urea.
7.4
7.4. Analysis
Comparison 7 Glucose+GAA versus glucose+nitrogen+fat, Outcome 4 Serum creatinine.

Update of

Similar articles

Cited by

References

References to studies included in this review

Abel 1973 {published data only}
    1. Abel RM, Beck CH Jr, Abbott WM, Ryan JA Jr, Barnett GO, Fischer JE. Improved survival from acute renal failure after treatment with intravenous essential L‐amino acids and glucose. Results of a prospective, double‐blind study. New England Journal of Medicine 1973;288(14):695‐9. [MEDLINE: ] - PubMed
De Aguilar 1982 {published data only}
    1. Capparros Fernandez de Aguilar T, Lopez Martinez J, Perez Picouto F. Parenteral nutrition and "hypermetabolic" acute renal failure. Revista Clinica Espanola 1982;165(4):239‐44. [MEDLINE: ] - PubMed
Feinstein 1981 {published data only}
    1. Feinstein EI, Blumenkrantz MJ, Healy M, Koffler A, Silberman H, Massry SG, et al. Clinical and metabolic responses to parenteral nutrition in acute renal failure. A controlled double‐blind study. Medicine 1981;60(2):124‐37. [MEDLINE: ] - PubMed
Feinstein 1983 {published data only}
    1. Feinstein EI, Kopple JD. Silberman H. Massry SG. Total parenteral nutrition with high or low nitrogen intakes in patients with acute renal failure. Kidney International‐Supplement 1983;16:S319‐23. [MEDLINE: ] - PubMed
Fiaccadori 2005 {published data only}
    1. Fiaccadori E, Maggiore U, Rotelli C, Giacosa R, Picetti E, Parenti E, et al. Effects of different energy intakes on nitrogen balance in patients with acute renal failure: a pilot study. Nephrology Dialysis Transplantation 2005;20(9):1976‐80. [MEDLINE: ] - PubMed
    1. Fiaccadori E, Rotelli F, Giacosa R, Picetti E, Maccari C, Maggiore U, et al. Energy intake and nitrogen balance in acute renal failure. [abstract no: SU‐PO234]. Journal of the American Society of Nephrology 2004;15(Oct):583A.
Martinez 1980 {published data only}
    1. Lopez Martinez J, Caparros T, Perez Picouto F, Lopez Diez F, Cereijo E. Parenteral nutrition in septic patients with acute renal failure in polyuric phase. Revista Clinica Espanola 1980;157(3):171‐7. [MEDLINE: ] - PubMed
Mirtallo 1982 {published data only}
    1. Mirtallo JM, Schneider PJ, Mavko K, Ruberg RL, Fabri PJ. A comparison of essential and general amino acid infusions in the nutritional support of patients with compromised renal function. Jpen: Journal of Parenteral & Enteral Nutrition 1982;6(2):109‐13. [MEDLINE: ] - PubMed
Singer 2007 {published data only}
    1. Singer P. High‐dose amino acid infusion preserves diuresis and improves nitrogen balance in non‐oliguric acute renal failure. Wiener Klinische Wochenschrift 2007;119(7‐8):218‐32. [MEDLINE: ] - PubMed

References to studies excluded from this review

Baek 1975 {published data only}
    1. Baek SM, Makabali GG, Bryan‐Brown CW, Kusek J, Shoemaker WC. The influence of parenteral nutrition on the course of acute renal failure. Surgery, Gynecology & Obstetrics 1975;14(3):405‐8. [MEDLINE: ] - PubMed
Berg 2007 {published data only}
    1. Berg A, Norberg A, Martling CR, Gamrin L, Rooyackers O, Wernerman J. Glutamine kinetics during intravenous glutamine supplementation in ICU patients on continuous renal replacement therapy. Intensive Care Medicine 2007 Apr;33(4):660‐6. [MEDLINE: ] - PubMed
Berger 2008 {published data only}
    1. Berger MM, Soguel L, Shenkin A, Revelly JP, Pinget C, Baines M, Chiolero RL. Influence of early antioxidant supplements on clinical evolution and organ function in critically ill cardiac surgery, major trauma, and subarachnoid hemorrhage patients. Critical Care 2008;12(4):R101. [EMBASE: 2008411873] - PMC - PubMed
Blumenkrantz 1978 {published data only}
    1. Blumenkrantz MJ, Kopple JD, Koffler A, Kamdar AK, Healy MD, Feinstein EI, et al. Total parenteral nutrition in the management of acute renal failure. American Journal of Clinical Nutrition 1978;31(10):1831‐40. [MEDLINE: ] - PubMed
Gjorup 1958 {published data only}
    1. Gjorup S. Protein‐sparing action of glucose administered intracavally in patients with acute renal failure. Acta Medica Scandinavica 1958;161(3):233‐41. - PubMed
Leonard 1975 {published data only}
    1. Leonard CD, Luke RG, Siegel RR. Parenteral essential amino acids in acute renal failure. Urology 1975;6(2):154‐7. [MEDLINE: ] - PubMed
Lopez Martinez 1988 {published data only}
    1. López Martinez J, Castrillo Garcia JM, Rapado Errasti A, Perez Picouto F, Caparros Fernandez de Aguilar T. Hypomagnesemia in acute non‐oliguric renal failure treated with parenteral nutrition. A study of its mechanisms. Revista Clínica Española 1988;183(6):289‐95. - PubMed
Mocan 1995 {published data only}
    1. Mocan MZ, Mocan H, Gacar MN, Ozgur GK, Uluutku MH. Effect of essential amino acid supplementation in acute renal failure. International Urology & Nephrology 1995;27(4):503‐10. [MEDLINE: ] - PubMed
Proietti 1978 {published data only}
    1. Proietti R, Pelosi G, Scrascia E, Magalini SI, Bondoli A. Acute renal failure: biochemical evaluation of total parenteral nutrition with essential L‐amino acids. Resuscitation 1978;6(3):191‐6. [MEDLINE: ] - PubMed
Smolle 1997 {published data only}
    1. Smolle KH, Kaufmann P, Fleck S, Lueger A, Mausser G, Polz W, et al. Influence of a novel amino acid solution (enriched with the dipeptide glycyl‐tyrosine) on plasma amino acid concentration of patients with acute renal failure. Clinical Nutrition 1997;16(5):239‐46. [EMBASE: 1998017394] - PubMed

Additional references

Anderson 1980
    1. Anderson RJ, Schrier RW. Acute renal failure. In: Stein JH editor(s) editor(s). Nephrology. Vol. 6, New York: Grune & Stratton, 1980.
Berger 2004
    1. Berger MM, Shenkin A, Revelly JP, Roberts E, Cayeux MC, Baines M, et al. Copper, selenium, zinc, and thiamine balances during continuous venovenous hemodiafiltration in critically ill patients. American Journal of Clinical Nutrition 2004;80(2):410‐6. [MEDLINE: ] - PubMed
Druml 1998
    1. Druml W, Schwarzenhofer M, Apsner R, Horl WH. Fat‐soluble vitamins in patients with acute renal failure. Mineral & Electrolyte Metabolism 1998;24(4):220‐6. [MEDLINE: ] - PubMed
Druml 2001
    1. Druml W. Nutrition management of acute renal failure. American Journal of Kidney Diseases 2001;37(1 Suppl 2):S89‐94. [MEDLINE: ] - PubMed
Feest 1993
    1. Feest TG, Round A, Hamad S. Incidence of severe acute renal failure in adults: results of a community based study. BMJ 1993;306(6876):481‐3. [MEDLINE: ] - PMC - PubMed
Fiaccadori 1999
    1. Fiaccadori E, Lombardi M, Leonardi S, Rotelli CF, Tortorella G, Borghetti A. Prevalence and clinical outcome associated with preexisting malnutrition in acute renal failure: a prospective cohort study. Journal of the American Society of Nephrology 1999;10(3):581‐93. [MEDLINE: ] - PubMed
Finn 1993
    1. Finn WF. Recovery from acute renal failure. In: Lazarus JM, Brenner BM editor(s). Acute renal failure. 3. New York: Churchill Livingstone, 1993:553‐96. [ISBN: 044308792X]
Fouque 1998
    1. Fouque D. Growth factors: future prospects in renal failure. Mineral & Electrolyte Metabolism 1998;24(1):27‐33. [MEDLINE: ] - PubMed
Freund 1980
    1. Freund H, Atamian S, Fischer JE. Comparative study of parenteral nutrition in renal failure using essential and nonessential amino acid containing solutions. Surgery, Gynecology & Obstetrics 1980;151(5):652‐56. [MEDLINE: ] - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Hou 1983
    1. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospital‐acquired renal insufficiency: a prospective study. American Journal of Medicine 1983;74(2):243‐8. [MEDLINE: ] - PubMed
Koretz 2001
    1. Koretz RL, Lipman TO, Klein S. AGA technical review on parenteral nutrition. Gastroenterology 2001;121(4):970‐1001. [MEDLINE: ] - PubMed
Koretz 2007
    1. Koretz RL, Avenell A, Lipman TO, Braunschweig CL, Milne AC. Does enteral nutrition affect clinical outcome? A systematic review of the randomized trials. American Journal of Gastroenterology 2007;102(2):412‐29. [MEDLINE: ] - PubMed
Naylor 1987
    1. Naylor CD, Detsky AS, O'Rourke K, Fonberg E. Does treatment with essential amino acids and hypertonic glucose improve survival in acute renal failure?: A meta‐analysis. Renal Failure 1987‐88;10(3‐4):141‐52. [MEDLINE: ] - PubMed
Novak 1997
    1. Novak I, Sramek V, Pittrova H, Rusavy P, Lacigova S, Eiselt M, et al. Glutamine and other amino acid losses during continuous venovenous hemodiafiltration. Artificial Organs 1997;21(5):359‐63. [MEDLINE: ] - PubMed
Santacruz 1996
    1. Santacruz F, Barreto S, Mayor MM, Cabrera W, Breuer N. Mortality in elderly patients with acute renal failure. Renal Failure 1996;18(4):601‐5. [MEDLINE: ] - PubMed
Schiffl 1994
    1. Schiffl H, Lang SM, Konig A, Strasser T, Haider MC, Held E. Biocompatible membranes in acute renal failure: prospective case‐controlled study. Lancet 1994;344(8922):570‐73. [MEDLINE: ] - PubMed
Sponsel 1995
    1. Sponsel H, Conger JD. Is parenteral nutrition therapy of value in acute renal failure patients?. American Journal of Kidney Diseases 1995;25(1):96‐102. [MEDLINE: ] - PubMed
Spreiter 1980
    1. Spreiter SC, Myers BD, Swenson RS. Protein‐energy requirements in subjects with acute renal failure receiving intermittent hemodialysis. American Journal of Clinical Nutrition 1980;33(7):1433‐7. [MEDLINE: ] - PubMed
Thadhani 1996
    1. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. New England Journal of Medicine 1996;334(22):1448‐60. [MEDLINE: ] - PubMed
Toback 1983
    1. Toback FG, Dodd RC, Maier ER, Havener LJ. Amino acid administration enhances renal protein metabolism after acute tubular necrosis. Nephron 1983;33(4):238‐43. [MEDLINE: ] - PubMed
Wolfson 1993
    1. Wolfson M, Kopple JD. Nutritional management of acute renal failure. In: Lazarus MJ, Brenner BM editor(s). Acute renal failure. 3. New York: Churchill Livingstone, 1993:467‐85. [ISBN: 044308792X]

References to other published versions of this review

Li 2010
    1. Li Y, Tang X, Zhang J, Wu T. Nutritional support for acute kidney injury. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD005426.pub2] - DOI - PubMed
Wu 2005
    1. Wu T, Li Y, Tang X, Zhang J. Nutritional support for acute renal failure. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD005426] - DOI

Publication types

MeSH terms

LinkOut - more resources